Company intelligence / Profile preview

Axogen, Inc.

Alachua, Florida, United Statesaxogeninc.com ↗

Ownership: Public · AXGN
Employees: ~400
Development stage: Commercial

Overview

Axogen’s products have been used in thousands of procedures with clinical outcomes published in over 180 peer-reviewed publications. The company’s Avance® Nerve Graft has demonstrated safety and efficacy for peripheral nerve repair. Revenue growth continues as adoption expands across surgical specialties. The company reported $38.2 million in Q2 revenue for an ~11% year-over-year increase as of mid–2023[5].

Therapeutic areas: Women's HealthNeurology
Modalities: Human tissue allografts (nerve grafts)Acellular nerve grafts/biologicsSurgical devices for nerve repair and protection[1][4]
Industry: Surgical Medical Devices

Drug pipeline

4 assets

Avance Nerve Graft

Commercial

Indications: Peripheral nerve repair

3 more assets in the full pipeline.

Request access →

Partnerships

No major pharmaceutical partnerships disclosed; collaborates with surgeons, hospitals, tissue banks/agencies.

Financials

Market cap: $2.5B
Total revenue: $69.7M
Enterprise value: $2.5B

Beyond the preview

Go deeper on Axogen, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axogen, Inc..

Explore the full profile